Adam Clauss

Adam Clauss is a dedicated scientific advisor and leader in drug discovery and development, specializing in regenerative dermatology and advanced therapies. They completed a PhD in Experimental Clinical Chemistry at Lund University from 2001 to 2006, followed by postdoctoral research at Harvard Medical School and Dana-Farber Cancer Institute. Adam’s experience includes roles at LEO Pharma, where they pioneered research in dermatological diseases and gene therapy, and most recently, they serve as the Vice President of Dermatology at SENISCA while also working as an adjunct researcher at Malmö University. Through their work, Adam has driven innovation, established collaborations, and led early research programs to address unmet medical needs in skin health.